GeneDx Holdings Corp. ( WGS) - Key Metrics
WGS Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $4.50 | -$0.66 | -$0.11 | -$0.28 |
| 2025Q3 | $4.05 | -$0.27 | $0.55 | $0.33 |
| 2025Q2 | $3.59 | $0.38 | $0.36 | $0.28 |
| 2025Q1 | $3.09 | -$0.23 | $0.36 | $0.14 |
WGS Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -49.49 |
| 2025Q3 | ? | -101.59 |
| 2025Q2 | ? | 61.02 |
| 2025Q1 | ? | -95.46 |
WGS
Price: $56.27
52 week price:
Earnings Per Share: -2.66 USD
Exchange: NMS
Sector: Healthcare
Industry: Diagnostics & Research
Country: United States
Market Capitalization: 1.6 billion